Establishment of the system for performing rapid preoperative BRCA1/2 genetic testing for breast cancer and clinical experience as a genetic counselor for a breast surgeon

Abstract

　The introduction of partial health insurance reimbursement for hereditary breast and ovarian cancer syndrome (HBOC) has resulted in an increase in the number of patients with breast cancer requesting BRCA1/2 genetic testing. In particular, patients who request this test for selecting an operative method for breast cancer require prompt implementation of the test, necessitating a review of our conventional genetic counseling (GC) system. In this report, we describe our efforts to address this issue and the experience of our first case in which preoperative BRCA1/2 genetic testing was performed as well as discuss future issues.